Kathleen Sugrue – Interview about the daily use of IBDoc® at ECCO 2020

Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.

The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.

Read More

• Alpha Laboratories
• Birmingham Calprotectin EQA Scheme
• EQUALIS Calprotectin EQA Scheme
• Crohn's and Colitis UK
• NHS - About Crohn's Disease
• NHS - About Ulcerative Colitis
• NICE Guideline NG129 – Crohn’s Disease: Management
• NICE Guidleine NG130 – Ulcerative Colitis: Management
• NHS - About IBD
• NHS - About IBS
• IBS Network
• Bowel Disease UK
• Bladder and Bowel Foundation
• British Society of Gastroenterology
• Guts UK Charity
• CICRA: better lives for children with crohns and colitis